SCHEMBL7306715

SCHEMBL7306715

N#Cc1cc([O])c2cccc(C#N)c2c1C#N

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 3/20 0.41
▸ CA2 P00918 3/20 0.41
▸ KDM4E B2RXH2 3/20 0.34
▸ ALDH1A1 P00352 3/20 0.34
▸ GAA P10253 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ CACNA1B Q00975 1/20 0.34
▸ APBA1 Q02410 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ MAP2K1 Q02750 1/20 0.33
▸ NCOA3 Q9Y6Q9 1/20 0.33
▸ DYRK1A Q13627 5/20 0.32
▸ HTT P42858 1/20 0.32
▸ MCL1 Q07820 2/20 0.32
▸ TSHR P16473 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ CLK1 P49759 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5252270 0.79 TSHR (0.44) CA1CA2KDM4EALDH1A1GAA
SCHEMBL5252267 0.79 KDM4E (0.38) CA1CA2KDM4EALDH1A1GAA
SCHEMBL7300758 0.76 PGR (0.31) KDM4EALDH1A1GAAMAPT
SCHEMBL7307006 0.72 KDM4E (0.49) CA1CA2KDM4EALDH1A1GAA
SCHEMBL7295484 0.72 CA1 (0.44) CA1CA2KDM4EALDH1A1GAA
SCHEMBL3026903 0.70 CA1 (0.41) CA1CA2KDM4EALDH1A1GAA
SCHEMBL819411 0.68 CA1 (0.49) CA1CA2KDM4EALDH1A1GAA
SCHEMBL7302562 0.67 CA1 (0.39) CA1CA2KDM4EALDH1A1GAA
SCHEMBL29501045 0.67 CYP1A2 (0.42) CA1CA2KDM4EALDH1A1GAA
SCHEMBL2584711 0.67 CYP1A2 (0.42) CA1CA2KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5629406-A AMINO ACID DERIVATIVES SANKYO COMPANY, LIMITED (JP) 1997-05-13 — — US disclosed
EP-0587311-A1 Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1994-03-16 — — EP disclosed
Send feedback